Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL278484 | 0.81 | LMNA (0.44) | LMNACYP2C9SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL967308 | 0.79 | LMNA (0.42) | LMNACYP2C9SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL14608744 | 0.79 | LMNA (0.42) | LMNACYP2C9SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL19198810 | 0.75 | SLC6A4 (0.41) | LMNACYP2C9SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL8373572 | 0.75 | SLC6A4 (0.40) | LMNACYP2C9SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL12158829 | 0.75 | LMNA (0.44) | LMNACYP2C9SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL3755807 | 0.75 | SLC6A4 (0.41) | LMNACYP2C9SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL8079753 | 0.74 | LMNA (0.42) | LMNACYP2C9SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL14298073 | 0.74 | LMNA (0.42) | LMNACYP2C9SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL7292734 | 0.74 | SLC6A4 (0.39) | LMNACYP2C9SLC6A4SLC6A3SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008098329-A2 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL PRODUCT, OBTAINING PROCESSES OF PHARMACEUTICAL COMPOUNDS AND USE OF SUCH COMPOUNDS FOR TREATING ERECTILE DYSFUNCTION | ACHÉ LABORATÓRIOS FARMACÊUTICOS S/A (BR) | 2008-08-21 | — | — | WO | claimed |
| CN-113527101-B | Novel compound, polymer, process for producing the same, photosensitive resin composition, pattern forming process, cured film, and electronic component | 信越化学工业株式会社 | 2024-04-23 | — | — | CN | disclosed |
| CN-113527680-B | Polymer, photosensitive resin composition, pattern forming method, cured film, and electronic component | 信越化学工业株式会社 | 2023-04-28 | — | — | CN | disclosed |
| WO-2008098329-A2 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL PRODUCT, OBTAINING PROCESSES OF PHARMACEUTICAL COMPOUNDS AND USE OF SUCH COMPOUNDS FOR TREATING ERECTILE DYSFUNCTION | ACHÉ LABORATÓRIOS FARMACÊUTICOS S/A (BR) | 2008-08-21 | — | — | WO | disclosed |
| US-6482837-B1 | Antimuscarinic compounds and methods for treatment of bladder diseases | UNIVERSITY OF ROCHESTER | 2002-11-19 | — | — | US | disclosed |